MedPath

Second Transplantation for Graft Failure

Not Applicable
Conditions
Stem Cell Transplant Complications
Graft Failure
Interventions
Other: second allogeneic stem cell transplantation
Registration Number
NCT03717545
Lead Sponsor
Peking University People's Hospital
Brief Summary

Graft failure is a lethal complication after allogeneic stem cell transplantation, which often need a salvage transplantation. However, the current outcome of second transplantation for graft failure is far from satisfactory. We performed a prospective single-arm study to investigate the safety and efficacy of a novel regimen.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
12
Inclusion Criteria
  • graft failure after first allogeneic stem cell transplantation
  • no active infection or GVHD or severe organ dysfunction
  • sign written informed consent
Exclusion Criteria
  • active infection, GVHD, organ failure
  • expected life < 28 days

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
intervention armsecond allogeneic stem cell transplantationsecond allogeneic stem cell transplantation
Primary Outcome Measures
NameTimeMethod
engraftment28 days after second transplantation

Engraftment of neutrophils was defined as the first of 3 consecutive days when the absolute neutrophil count achieved 500/uL.

Secondary Outcome Measures
NameTimeMethod
TRM at 28 day28 days after second transplantation

treatment-related mortality(TRM) was defined as death from any cause other than relapse.

Overall survival at 100dday100 after second transplantation

Overall survival at 100d

TRM at 100dday 100 after second transplant

treatment-related mortality(TRM) was defined as death from any cause other than relapse.

Trial Locations

Locations (1)

Peking University People's Hospital

🇨🇳

Beijing, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath